PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 223 filers reported holding PDL BIOPHARMA INC in Q4 2014. The put-call ratio across all filers is 2.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $7,854,000 | -31.6% | 2,218,505 | -2.9% | 0.53% | -38.1% |
| Q3 2015 | $11,489,000 | -26.6% | 2,284,013 | -6.2% | 0.86% | -0.3% |
| Q2 2015 | $15,660,000 | -0.6% | 2,435,411 | +8.7% | 0.86% | -3.6% |
| Q1 2015 | $15,758,000 | +71.9% | 2,239,893 | +88.3% | 0.90% | +76.0% |
| Q4 2014 | $9,169,000 | +0.4% | 1,189,286 | -2.7% | 0.51% | +2.2% |
| Q3 2014 | $9,130,000 | -18.7% | 1,222,184 | +5.3% | 0.50% | -23.0% |
| Q2 2014 | $11,234,000 | +38.3% | 1,160,576 | +18.7% | 0.65% | +17.4% |
| Q1 2014 | $8,124,000 | -26.1% | 977,601 | -24.9% | 0.55% | -40.6% |
| Q4 2013 | $10,991,000 | +17.5% | 1,302,197 | +10.9% | 0.93% | -16.3% |
| Q3 2013 | $9,356,000 | +14.3% | 1,173,857 | +10.7% | 1.11% | -17.2% |
| Q2 2013 | $8,184,000 | – | 1,060,040 | – | 1.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |